Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2019
  2. Published

    Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals

    Suppli, M. P., Rigbolt, K. T. G., Veidal, S. S., Heeboll, S., Eriksen, P. L., Demant, M., Bagger, J. I., Nielsen, J. C., Oro, D., Thrane, S. W., Lund, A., Strandberg, C., Konig, M. J., Vilsbøll, Tina, Vrang, N., Thomsen, K. L., Gronbaek, H., Jelsing, J., Hansen, H. H. & Knop, Filip Krag, 2019, In: American Journal of Physiology: Gastrointestinal and Liver Physiology. 316, 4, p. G462-G472 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients

    Svensson, C. K., Larsen, J. R., Vedtofte, L., Jakobsen, M. S. L., Jespersen, H. R., Jakobsen, M. I., Koyuncu, K., Schjerning, O., Nielsen, J., Ekstrøm, Claus Thorn, Correll, C. U., Vilsbøll, Tina & Fink-Jensen, Anders, 2019, In: Acta Psychiatrica Scandinavica. 139, 1, p. 26-36 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Lean Women with Polycystic Ovary Syndrome and Insulin Resistance Have Normal Incretin Effect, which Is Unaffected by Metformin Therapy

    Vedtofte, L., Foghsgaard, S., Zierau, L., Vilsbøll, Tina & Knop, Filip Krag, 2019, In: Diabetes. 68, Supplement 1, 1 p., 1186-P.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  5. Published

    Dapagliflozin plus saxagliptin add-on therapy compared with insulin in patients with type 2 diabetes poorly controlled by metformin with or without sulfonylurea therapy: A randomized clinical trial

    Vilsbøll, Tina, Ekholm, E., Johnsson, E., Dronamraju, N., Jabbour, S. & Lind, M., 2019, In: Diabetes Care. 42, 8, p. 1464-1472 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

    Vilsbøll, Tina, Blevins, T. C., Jodar, E., Poulter, N., Tentolouris, N., Ross Agner, B. F., Lehmann, L. & Leiter, L. A., 2019, In: Diabetes, Obesity and Metabolism. 21, 6, p. 1506-1512 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 Next

ID: 33056950